Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 25;9(11):146.
doi: 10.3390/cancers9110146.

Advances in Precision Medicine: Tailoring Individualized Therapies

Kyle B Matchett  1 , Niamh Lynam-Lennon  2 , R William Watson  3 , James A L Brown  4
Affiliations

Advances in Precision Medicine: Tailoring Individualized Therapies

Kyle B Matchett et al. Cancers (Basel). .

Abstract

The traditional bench-to-bedside pipeline involves using model systems and patient samples to provide insights into pathways deregulated in cancer. This discovery reveals new biomarkers and therapeutic targets, ultimately stratifying patients and informing cohort-based treatment options. Precision medicine (molecular profiling of individual tumors combined with established clinical-pathological parameters) reveals, in real-time, individual patient's diagnostic and prognostic risk profile, informing tailored and tumor-specific treatment plans. Here we discuss advances in precision medicine presented at the Irish Association for Cancer Research Annual Meeting, highlighting examples where personalized medicine approaches have led to precision discovery in individual tumors, informing customized treatment programs.

Keywords: Ireland Cancer Meeting; PDX; Xenografts; avatar, precision medicine; personalized; profiling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Mirnezami R., Nicholson J., Darzi A. Preparing for precision medicine. N. Engl. J. Med. 2012;366:489–491. doi: 10.1056/NEJMp1114866. - DOI - PubMed
    1. Ciardiello F., Arnold D., Casali P.G., Cervantes A., Douillard J.Y., Eggermont A., Eniu A., McGregor K., Peters S., Piccart M., et al. Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: A position paper by the European Society for Medical Oncology (ESMO) Ann. Oncol. 2014;25:1673–1678. doi: 10.1093/annonc/mdu217. - DOI - PubMed
    1. Ashley E.A. Towards precision medicine. Nat. Rev. Genet. 2016;17:507–522. doi: 10.1038/nrg.2016.86. - DOI - PubMed
    1. Chen R., Snyder M. Promise of personalized omics to precision medicine. Wiley Interdiscip. Rev. Syst. Biol. Med. 2013;5:73–82. doi: 10.1002/wsbm.1198. - DOI - PMC - PubMed
    1. Burrell R.A., McGranahan N., Bartek J., Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013;501:338–345. doi: 10.1038/nature12625. - DOI - PubMed

Publication types